ASTON HEALTH ADVANCES GOVERNMENT STRATEGY IN CANCER PREVENTION

Publication date: 10 july 2019

Today one of the key government priorities is enhancing public health and prevention activities. The long-term National Strategy for Cancer Control up to 2030 has established the vision, goals and focus areas for government efforts in cancer prevention. The medical community sees as the most urgent reducing overall cancer-related mortality, including premature mortality in working age population, as well as preventing and bringing down cancer-related disability rates through early detection and improved quality and access to care, better drugs and provision of high-technology medical services, rehabilitation and palliative care. All these initiatives have been introduced to sustain and enhance the national human capital in the long run. (Source)*

Aston Health's Laboratory Diagnostics Programs help address challenges associated with timely screening, diagnosis verification, providing treatment rationale and monitoring treatment effectiveness and outcomes.

Aston implements various screening and diagnostic projects in Oncology, Onco-Hematology, Infectious Diseases, Orphan Diseases and other therapeutic areas.

It has well-established ties with multiple laboratory chains throughout Russia, which provide clinical data in line with the best international standards and practices.

The company has unique resources and capabilities to support laboratory diagnostics programs across Russia and EAEU countries.

Also, working in close contact with the medical community Aston develops and launches Patient Support Programs to bridge the gap between diagnosis and treatment, target patient adherence and, eventually, improve outcomes.